sesamol has been researched along with cyclic gmp in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, H; Chen, PR; Lee, CC; Liu, TL; Tsai, CE | 1 |
| Chang, CC; Chiang, CW; Chou, DS; Fong, TH; Hsiao, G; Jayakumar, T; Lu, WJ; Ong, ET; Sheu, JR | 1 |
2 other study(ies) available for sesamol and cyclic gmp
| Article | Year |
|---|---|
Sesamol induces nitric oxide release from human umbilical vein endothelial cells.
Topics: Androstadienes; Benzodioxoles; Cells, Cultured; Cyclic GMP; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Phenols; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction; Umbilical Veins; Wortmannin | 2005 |
Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
Topics: Animals; Antioxidants; Benzodioxoles; Blood Platelets; Cell Adhesion Molecules; Collagen; Cyclic AMP; Cyclic GMP; Humans; Mice; Microfilament Proteins; Nitric Oxide Synthase Type III; p38 Mitogen-Activated Protein Kinases; Phenols; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors | 2010 |